IL117824A - Pharmaceutical compositions containing 2-aryl-imidazol¬1,2-a¾pyridine-3-acetamide derivatives for treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia - Google Patents

Pharmaceutical compositions containing 2-aryl-imidazol¬1,2-a¾pyridine-3-acetamide derivatives for treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia

Info

Publication number
IL117824A
IL117824A IL11782496A IL11782496A IL117824A IL 117824 A IL117824 A IL 117824A IL 11782496 A IL11782496 A IL 11782496A IL 11782496 A IL11782496 A IL 11782496A IL 117824 A IL117824 A IL 117824A
Authority
IL
Israel
Prior art keywords
imidazol
dysfunction
aryl
treatment
pharmaceutical compositions
Prior art date
Application number
IL11782496A
Other languages
English (en)
Other versions
IL117824A0 (en
Original Assignee
Clarendon Trading E Investimen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clarendon Trading E Investimen filed Critical Clarendon Trading E Investimen
Publication of IL117824A0 publication Critical patent/IL117824A0/xx
Publication of IL117824A publication Critical patent/IL117824A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11782496A 1995-04-07 1996-04-03 Pharmaceutical compositions containing 2-aryl-imidazol¬1,2-a¾pyridine-3-acetamide derivatives for treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia IL117824A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000223A IT1276522B1 (it) 1995-04-07 1995-04-07 Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei

Publications (2)

Publication Number Publication Date
IL117824A0 IL117824A0 (en) 1996-08-04
IL117824A true IL117824A (en) 2000-08-31

Family

ID=11403250

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11782496A IL117824A (en) 1995-04-07 1996-04-03 Pharmaceutical compositions containing 2-aryl-imidazol¬1,2-a¾pyridine-3-acetamide derivatives for treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia

Country Status (25)

Country Link
US (1) US5891891A (fr)
EP (1) EP0819002B1 (fr)
JP (1) JP4049390B2 (fr)
KR (1) KR100425628B1 (fr)
CN (1) CN1198612C (fr)
AR (1) AR003414A1 (fr)
AT (1) ATE222763T1 (fr)
AU (1) AU707759B2 (fr)
CA (1) CA2217590C (fr)
CZ (1) CZ292020B6 (fr)
DE (1) DE69623271T2 (fr)
DK (1) DK0819002T3 (fr)
EA (1) EA000396B1 (fr)
ES (1) ES2182967T3 (fr)
HU (1) HUP9900733A3 (fr)
IL (1) IL117824A (fr)
IT (1) IT1276522B1 (fr)
MX (1) MX9707712A (fr)
NO (1) NO315408B1 (fr)
NZ (1) NZ304107A (fr)
PL (1) PL322647A1 (fr)
PT (1) PT819002E (fr)
TW (1) TW450816B (fr)
WO (1) WO1996031210A1 (fr)
ZA (1) ZA962711B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6333345B1 (en) 1999-05-14 2001-12-25 Sepracor, Inc. Methods of using and compositions comprising N-desmethylzolpidem
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
AU5066101A (en) * 2000-04-13 2001-10-30 Synthon B.V. Modified release formulations containing a hypnotic agent
CZ20023775A3 (cs) * 2000-04-24 2003-10-15 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrát
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10117183A1 (de) * 2001-04-05 2002-10-10 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
KR20060023129A (ko) 2003-05-19 2006-03-13 사이언콤 리미티드 졸피뎀의 추가 치료적 사용
GB0311457D0 (en) * 2003-05-19 2003-06-25 Sciencom Ltd New therapeutic use
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
WO2005079851A2 (fr) 2004-02-18 2005-09-01 Sepracor, Inc. Therapie combinee dopamine-agoniste pour ameliorer la qualite du sommeil
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
AU2006322314A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
GB2443928A (en) * 2006-11-08 2008-05-21 Regen Therapeutics Plc Transdermal pharmaceutical composition comprising Zolpidem
GB0809936D0 (en) * 2008-05-30 2008-07-09 Regen Therapeutics Plc Therapeutic use of zolpidem
EP3468545A4 (fr) 2016-06-08 2020-07-22 President and Fellows of Harvard College Procédés et compositions pour réduire le dysfonctionnement tactile et l'anxiété associés au trouble du spectre de l'autisme, au syndrome de rett et au syndrome de l'x fragile
CA3099751A1 (fr) 2018-05-22 2019-11-28 President And Fellows Of Harvard College Compositions et procedes permettant de reduire un dysfonctionnement tactile, l'anxiete et une deficience sociale
EP3801512A4 (fr) 2018-05-29 2022-01-19 President and Fellows of Harvard College Compositions et méthodes pour réduire un dysfonctionnement tactile, l'anxiété et une déficience sociale
WO2020198275A1 (fr) 2019-03-25 2020-10-01 President And Fellows Of Harvard College Compositions et méthodes pour réduire un dysfonctionnement tactile, l'anxiété et une déficience sociale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
US5032595A (en) * 1989-11-24 1991-07-16 Fidia-Georgetown Institute For The Neurosciences Method of stimulating steroidogenesis with alpidem
US5206382A (en) * 1991-06-27 1993-04-27 Fidia Georgetown Institute For The Neurosciences Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders

Also Published As

Publication number Publication date
DE69623271T2 (de) 2003-07-24
ES2182967T3 (es) 2003-03-16
DK0819002T3 (da) 2003-01-06
EP0819002B1 (fr) 2002-08-28
WO1996031210A1 (fr) 1996-10-10
IT1276522B1 (it) 1997-10-31
DE69623271D1 (de) 2002-10-02
EA000396B1 (ru) 1999-06-24
HUP9900733A2 (hu) 1999-07-28
AR003414A1 (es) 1998-08-05
ATE222763T1 (de) 2002-09-15
TW450816B (en) 2001-08-21
KR19980703707A (ko) 1998-12-05
PT819002E (pt) 2003-01-31
NO974603D0 (no) 1997-10-06
CZ292020B6 (cs) 2003-07-16
NZ304107A (en) 2000-12-22
IL117824A0 (en) 1996-08-04
AU707759B2 (en) 1999-07-22
KR100425628B1 (ko) 2004-06-23
ZA962711B (en) 1996-07-30
MX9707712A (es) 1998-03-31
EP0819002A1 (fr) 1998-01-21
JPH11503149A (ja) 1999-03-23
NO974603L (no) 1997-11-24
NO315408B1 (no) 2003-09-01
CA2217590C (fr) 2008-08-12
ITRM950223A1 (it) 1996-10-07
US5891891A (en) 1999-04-06
CN1183719A (zh) 1998-06-03
JP4049390B2 (ja) 2008-02-20
CA2217590A1 (fr) 1996-10-10
AU5120096A (en) 1996-10-23
CN1198612C (zh) 2005-04-27
ITRM950223A0 (it) 1995-04-07
CZ316797A3 (cs) 1998-05-13
EA199700308A1 (ru) 1998-04-30
PL322647A1 (en) 1998-02-16
HUP9900733A3 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
IL117824A (en) Pharmaceutical compositions containing 2-aryl-imidazol¬1,2-a¾pyridine-3-acetamide derivatives for treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia
GR900300093T1 (en) Composition for the treatment of erectile dysfunction
IL98393A0 (en) Thiophene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL107978A0 (en) Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
HUT72448A (en) O-, n- ors-containing heterobicyclic compounds, pharmaceutical compositions comprising them and process for their preparation
HUP9800138A3 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use
IL98873A0 (en) Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0451009A3 (en) Pharmaceutical composition comprising opiate antagonists for the treatment of emotional numbness
HUP0200287A3 (en) Pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders
GB8914060D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914040D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
IL104706A0 (en) 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-ones and process for the preparation thereof
GB8914061D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
AU4530989A (en) Pharmaceutical composition for the treatment of cerebral edema
IL103151A0 (en) Beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2135709A1 (fr) Derives de melatonine servant au traitement des troubles du sommeil
GB8914062D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
IL108197A0 (en) Pharmaceutical composition for preventing or treating arterioscleriosis
IL117619A0 (en) Diazabicyclo [3.3.1] nonane derivatives pharmaceutical compositions containing the same and methods for the production thereof
IL105285A0 (en) Compositions for the treatment of diabetes
EP0523534A3 (en) Process for the preparation of polyenes
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL107122A0 (en) 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired